ALFA Filings
Every announcement, straight from the exchange
Every Alembic Pharmaceuticals regulatory approval announcement on NSE and BSE, newest first, each with its own page.
Time
2 announcements with these filters
Alembic Pharmaceuticals received USFDA final approval for Valganciclovir for Oral Solution, 50 mg/mL. This adds to its cumulative 247 USFDA ANDA approvals.
Alembic Pharmaceuticals received USFDA final approval for Ciprofloxacin and Dexamethasone Otic Suspension USP. This drug is therapeutically equivalent to the reference product Ciprodex Otic Suspension.